Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Ajanta Pharma Ltd.

BSE: 532331 | NSE: AJANTPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE031B01049 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 20, 16:01
2904.20 -41.95 (-1.42%)
Volume
AVERAGE VOLUME
5-Day
3,885
10-Day
27,250
30-Day
17,769
5,209
  • Prev. Close

    2946.15

  • Open Price

    2946.90

  • Bid Price (Qty.)

    2874.00 (10)

  • Offer Price (Qty.)

    3049.80 (15)

NSE Live

Mar 20, 15:56
2904.70 -39.20 (-1.33%)
Volume
AVERAGE VOLUME
5-Day
150,598
10-Day
154,384
30-Day
120,272
111,373
  • Prev. Close

    2943.90

  • Open Price

    2973.20

  • Bid Price (Qty.)

    2904.70 (1058)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) Mar 10 Mar 09 Mar 08 Mar 07 Mar 06  
Per Share Ratios  
Basic EPS (Rs.) 24.19 18.12 15.08 11.62 8.77  
Diluted EPS (Rs.) 24.19 18.12 15.08 11.62 8.77  
Cash EPS (Rs.) 40.94 29.27 20.99 17.36 14.02  
Book Value [ExclRevalReserve]/Share (Rs.) 149.12 128.98 113.76 102.25 92.95  
Book Value [InclRevalReserve]/Share (Rs.) 149.12 128.98 113.76 102.25 92.95  
Dividend / Share(Rs.) 3.50 2.50 2.50 2.00 1.50  
Revenue from Operations/Share (Rs.) 323.54 270.71 241.53 202.35 174.64  
PBDIT/Share (Rs.) 61.46 51.81 39.59 31.12 24.75  
PBIT/Share (Rs.) 44.71 40.67 33.68 25.37 19.50  
PBT/Share (Rs.) 28.54 21.99 20.89 15.58 10.05  
Net Profit/Share (Rs.) 24.19 18.12 15.08 11.62 8.77  
Profitability Ratios  
PBDIT Margin (%) 18.99 19.14 16.39 15.37 14.16  
PBIT Margin (%) 13.81 15.02 13.94 12.53 11.16  
PBT Margin (%) 8.81 8.12 8.64 7.69 5.75  
Net Profit Margin (%) 7.47 6.69 6.24 5.74 5.02  
Return on Networth / Equity (%) 16.22 14.05 13.25 11.36 9.43  
Return on Capital Employed (%) 8.63 6.83 7.68 8.04 7.13  
Return on Assets (%) 6.12 4.65 5.02 5.03 4.65  
Total Debt/Equity (X) 1.16 1.58 1.23 0.90 0.75  
Asset Turnover Ratio (%) 81.93 69.49 80.43 87.69 92.70  
Liquidity Ratios  
Current Ratio (X) 1.73 1.67 1.70 1.74 1.88  
Quick Ratio (X) 0.96 0.99 0.96 1.06 1.06  
Inventory Turnover Ratio (X) 3.63 3.23 3.13 3.46 3.28  
Dividend Payout Ratio (NP) (%) 14.35 13.69 16.45 17.08 16.97  
Dividend Payout Ratio (CP) (%) 8.48 8.47 11.82 11.43 10.62  
Earnings Retention Ratio (%) 85.65 86.31 83.55 82.92 83.03  
Cash Earnings Retention Ratio (%) 91.52 91.53 88.18 88.57 89.38  
Valuation Ratios  
Enterprise Value (Cr.) 412.75 293.48 254.58 187.17 167.65  
EV/Net Operating Revenue (X) 1.08 0.92 0.89 0.78 0.81  
EV/EBITDA (X) 5.69 4.80 5.45 5.10 5.74  
MarketCap/Net Operating Revenue (X) 0.56 0.19 0.33 0.36 0.42  
Retention Ratios (%) 85.64 86.30 83.54 82.91 83.02  
Price/BV (X) 1.22 0.40 0.70 0.70 0.80  
Price/Net Operating Revenue 0.56 0.19 0.33 0.36 0.42  
Earnings Yield 0.13 0.35 0.19 0.16 0.12  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347